跳到正文
Yakov Pakhomov MD, PhD· @yakov_pakhomov · X·· 12 小时前评分60
正文 · 原文

@michaelzlin Look at the numbers at risk: at 30 mo it's 10 vs 3 patients, at 35 mo it's 0 vs 0. That "convergence" is one or two events in a handful of people — the CI there is the width of the plot. Median follow-up is 24.6 mo; the curve tells you nothing beyond that. #ESMO26

热度 0 · 0 赞 · 0 回复 · 0 转发

来源:Yakov Pakhomov MD, PhD · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org